Batulicin Nusantara Maritim Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Batulicin Nusantara Maritim Tbk trades at Rp930 (market cap 3.22T, 11.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Batulicin Nusantara Maritim Tbk is far larger — about 19.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (214.9K versus 11.6K). Which is the better fit depends on your goals.
| BESS | OBAT | |
|---|---|---|
Market Cap | 3.22T | 164.65B |
Volume | 11.6K | 214.9K |
Lot | 116 | 2.15K |
Turnover | 10.49M | 51.97M |
Average Price | 904.18 | 241.85 |
Value | 10.49M | 51.97M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Batulicin Nusantara Maritim Tbk (the “Company”) was established based on Notarial Deed No. 53 dated May 25, 2011 of Muhammad Faried Zain, S.H., M.H., notary in Banjarmasin. The Company’s immediate Parent Company is PT Batulicin Enam Sembilan Transportasi, and its Ultimate Parent Company is PT Batulicin Enam Sembilan. The Company started its commercial operations in 2012.
Read more on BESS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →